Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
0.95
-0.04 (-4.50%)
At close: Sep 17, 2025, 3:59 PM
0.96
1.02%
After-hours: Sep 17, 2025, 07:56 PM EDT
-4.50% (1D)
| Bid | 0.93 |
| Market Cap | 10.26M |
| Revenue (ttm) | 5.39M |
| Net Income (ttm) | -14.61M |
| EPS (ttm) | -1.35 |
| PE Ratio (ttm) | -0.7 |
| Forward PE | -0.58 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 1.01 |
| Volume | 164,519 |
| Avg. Volume (20D) | 2,031,793 |
| Open | 0.99 |
| Previous Close | 0.99 |
| Day's Range | 0.95 - 1.02 |
| 52-Week Range | 0.81 - 5.95 |
| Beta | 1.52 |
| Ex-Dividend Date | n/a |
About MRKR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRKR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRKR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsMarker Therapeutics Inc. is scheduled to release its earnings on
Nov 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-20.63%
Marker Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
6 months ago
+33.33%
Marker Therapeutics shares are trading higher after Canaccord Genuity initiated coverage on the stock with a Buy rating and announced a price target of $8.
